ski-g-801
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 23, 2018 (NCT03564288)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tyrosine-protein kinase receptor UFOINHIBITOR
AXL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05971862 | Phase 1 | Jan 25, 2022 | Oscotec Inc. |
| NCT03564288 | Phase 1 | Feb 23, 2018 | Innovative Clinical Research, Inc., Oscotec Inc., PPD |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Oscotec Inc. | For profit | 2 | 2 | 1 | 2018 |
| Innovative Clinical Research, Inc. | For profit | 1 | 0 | 1 | 2018 |
| PPD | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1